In a filing, Viking Therapeutics Inc revealed its Director Rouan Sarah Kathryn acquired Company’s shares for reported $29943.0 on Mar 31 ’25. In the deal valued at $24.15 per share,1,240 shares were bought. As a result of this transaction, Rouan Sarah Kathryn now holds 1,240 shares worth roughly $32339.199999999997.
Then, Lian Brian sold 194,490 shares, generating $8,313,601 in total proceeds. Upon selling the shares at $42.75, the President & CEO now owns 2,366,570 shares.
Before that, Mancini Marianna sold 54,215 shares. Viking Therapeutics Inc shares valued at $2,317,599 were divested by the Chief Operating Officer at a price of $42.75 per share. As a result of the transaction, Mancini Marianna now holds 374,134 shares, worth roughly $9.76 million.
Cantor Fitzgerald initiated its Viking Therapeutics Inc [VKTX] rating to an Overweight in a research note published on April 29, 2025; the price target was $104. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in early April with a ‘”a Neutral”‘ rating. Scotiabank began covering VKTX with “Sector outperform” recommendation on February 13, 2025. Citigroup started covering the stock on February 07, 2025. It rated VKTX as “a Neutral”.
Price Performance Review of VKTX
On Friday, Viking Therapeutics Inc [NASDAQ:VKTX] saw its stock fall -8.75% to $26.08. Over the last five days, the stock has lost -6.29%. Viking Therapeutics Inc shares have fallen nearly -35.19% since the year began. Nevertheless, the stocks have fallen -50.54% over the past one year. While a 52-week high of $81.73 was reached on 01/06/25, a 52-week low of $18.92 was recorded on 04/09/25.
Levels Of Support And Resistance For VKTX Stock
The 24-hour chart illustrates a support level at 25.06, which if violated will result in even more drops to 24.05. On the upside, there is a resistance level at 27.64. A further resistance level may holdings at 29.21.
How much short interest is there in Viking Therapeutics Inc?
A steep rise in short interest was recorded in Viking Therapeutics Inc stocks on 2025-05-30, growing by 0.16 million shares to a total of 26.71 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 26.54 million shares. There was a rise of 0.62%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 02, 2024 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating .
